Iyer Guest Speaker at India Symposium

Dr. Kris Iyer, CSO of Spring Bank Pharmaceuticals is Invited Speaker
at the International Symposium In India.  “Innovations in Pharmaceutical Sciences and Technology”

Milford, MA. November 12, 2010. Dr. Kris Iyer, Chief Scientific Officer and Co-Founder of Spring Bank Pharmaceuticals, Inc. will present an invited talk at the 6th International Symposium on “Innovations in Pharmaceutical Sciences and Technology,” to be held November 26-28, 2010 in Ahmedabad, India.

The title of Dr. Iyer’s talk is “Harnessing cellular viral sensors for the development of antiviral therapeutics”. Dr. Iyer will be presenting novel strategies that have been developed at Spring Bank for the discovery of Antiviral Therapeutics with a focus on hepatitis viruses.

Spring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on our proprietary platform technology, we are developing a pipeline of products representing a new class of pharmaceuticals we call small molecule nucleic acid hybrids “SMNH” with a wide range of applications and multi-billion dollar market potential. For more on Spring Bank, please visit http://www.springbankpharm.com

About Hepatitis

Over 350 million people are chronically infected with HBV virus worldwide. The HBV virus is a DNA virus which incorporates into the hepatocyte DNA. Read More >>

Approximately 170 million people worldwide and 4 million in the United States are infected with HCV. HCV infection is one of the most significant public health threats facing Americans.
Read More >>